JENNIFER DOCAMPO: Open Payments
NPI 1326491218 · FALLS CHURCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,668 in 42 payments from 16 companies in 2025. Trend: 2023 $1,258 · 2024 $566 · 2025 $2,668
Travel & lodging: $1,554Food & beverage: $1,114
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 11 | $1,570 |
| Medtronic, Inc. | 4 | $514 |
| BridgeBio Pharma, Inc. | 4 | $96 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| Merck Sharp & Dohme LLC | 2 | $57 |
| Amgen Inc. | 3 | $54 |
| SCPHARMACEUTICALS INC. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| ABIOMED | 2 | $32 |
Products named: NAVITOR, COREVALVE EVOLUT R, Attruby, LEQVIO, VERQUVO, REPATHA, FUROSCIX, NEXLETOL.
Industry payments across VA — which companies pay providers there.
